In addition, CKD patients with comorbidities often receive regular monitoring and treatment for mineral and bone disorders, including vitamin D supplementation, phosphate binders, and parathyroid hormone modulators [13,32]. The gene discussed is PTH; the disease is chronic kidney disease.